Treatment horizon in multiple myeloma.

OBJECTIVES:This paper reviews current and emerging therapies for multiple myeloma (MM). METHODS:Narrative review. RESULTS:MM is a complex, heterogenous condition, and in recent years there has been an expansion in the number and range of treatments. Several new treatment approaches, including enhanced monoclonal antibodies, antibody-drug conjugates, bispecific T-cell engagers, and chimeric antigen-T-cell therapy are under development. CONCLUSIONS:The emergence of new treatments that aim to tackle MM-associated immune dysfunction has led to improvements in overall survival.